Dow Jones

43 953,52

-1,33%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Orgenesis Inc (QX) (ORGS)
Orgenesis Inc (QX) (ORGS) Actualités

ORGS

Orgenesis (QX) (ORGS)

Orgenesis Inc (QX)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:ORGS

Date	Heure	Source	Titre	Symbole	Société
27/12/2024	22h30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ORGS	Orgenesis Inc (QX)
16/12/2024	20h42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ORGS	Orgenesis Inc (QX)
04/09/2013	23h15	Marketwired	Orgenesis to Present at the 2013 Gateway Conference on September 10	USOTC:ORGS	Orgenesis Inc (QX)
18/07/2013	20h00	GlobeNewswire Inc.	Dr. David Sidransky Appointed to Orgenesis' Board of Directors	USOTC:ORGS	Orgenesis Inc (QX)
30/05/2013	20h30	GlobeNewswire Inc.	Orgenesis to Present Updates at Two Key June Conferences	USOTC:ORGS	Orgenesis Inc (QX)
09/05/2013	13h55	GlobeNewswire Inc.	Orgenesis and ATMI Enter Into Process Development Agreement	USOTC:ORGS	Orgenesis Inc (QX)
11/04/2013	14h15	GlobeNewswire Inc.	Leading Diabetes Expert, Jay S. Skyler, M.D., Joins Orgenesis' Scientific Advisory Board	USOTC:ORGS	Orgenesis Inc (QX)
20/02/2013	20h11	GlobeNewswire Inc.	Orgenesis to Present at ATTD 2013	USOTC:ORGS	Orgenesis Inc (QX)
07/01/2013	14h00	GlobeNewswire Inc.	Orgenesis Announces Management Changes	USOTC:ORGS	Orgenesis Inc (QX)
09/11/2012	12h02	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:ORGS	Orgenesis Inc (QX)
09/11/2012	12h02	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ORGS	Orgenesis Inc (QX)
15/10/2012	22h45	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:ORGS	Orgenesis Inc (QX)
08/05/2012	15h00	Marketwired	Orgenesis Inc. Increases Depth of Governance With Latest Board Appointee	USOTC:ORGS	Orgenesis Inc (QX)
30/04/2012	15h00	Marketwired	Orgenesis Inc. Appoints Experienced Pubco Development Professional to Board of Directors	USOTC:ORGS	Orgenesis Inc (QX)
23/04/2012	22h36	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:ORGS	Orgenesis Inc (QX)
23/04/2012	15h00	Marketwired	Orgenesis Inc. Appoints Ex FDA Officer and Diabetes Authority to Scientific Advisory Board	USOTC:ORGS	Orgenesis Inc (QX)
17/04/2012	22h12	Edgar (US Regulatory)	Amended Notification that Quarterly Report will be submitted late (NT 10-Q/A)	USOTC:ORGS	Orgenesis Inc (QX)
17/04/2012	15h00	Marketwired	Orgenesis Inc. Appoints Biotech Veteran to Board of Directors	USOTC:ORGS	Orgenesis Inc (QX)
16/04/2012	18h24	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:ORGS	Orgenesis Inc (QX)
11/04/2012	15h00	Marketwired	Orgenesis Inc. Enters Into Agreement to Commence Advanced Studies for Proposed Diabetes Treatment	USOTC:ORGS	Orgenesis Inc (QX)
03/04/2012	15h00	Marketwired	Orgenesis Inc. Announces Appointment of Senior Leadership	USOTC:ORGS	Orgenesis Inc (QX)
20/03/2012	13h00	Marketwired	Orgenesis Inc. Announces Acceptance of Technology by U.S. Patent Office	USOTC:ORGS	Orgenesis Inc (QX)
16/03/2012	19h30	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	USOTC:ORGS	Orgenesis Inc (QX)
29/02/2012	18h18	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:ORGS	Orgenesis Inc (QX)
29/02/2012	18h14	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:ORGS	Orgenesis Inc (QX)
14/11/2011	20h52	Edgar (US Regulatory)	Amended Quarterly Report (10-Q/A)	USOTC:ORGS	Orgenesis Inc (QX)